MHRA asked whether in his view there was any way that patients who were more at
risk of prolonged withdrawal reactions could be identified. Prof Healy said that he felt
that from his experience women seemed to be more at risk than men but it was
unknown whether this was because more women than men were treated with SSRIs.
http://bobfiddaman.blogspot.com/2011/11/mhra-meeting-to-discuss-awareness-and.html
MHRA said that their review of the issue had not identified any link between the risk
of withdrawal reactions and the gender of the patient. Prof Healy considered that
there was little evidence available on how to manage patients who had difficulty
withdrawing from SSRIs. All agreed that this was a very difficult area to study as the
management of the patient would differ depending on the patient
risk of prolonged withdrawal reactions could be identified. Prof Healy said that he felt
that from his experience women seemed to be more at risk than men but it was
unknown whether this was because more women than men were treated with SSRIs.
http://bobfiddaman.blogspot.com/2011/11/mhra-meeting-to-discuss-awareness-and.html
MHRA said that their review of the issue had not identified any link between the risk
of withdrawal reactions and the gender of the patient. Prof Healy considered that
there was little evidence available on how to manage patients who had difficulty
withdrawing from SSRIs. All agreed that this was a very difficult area to study as the
management of the patient would differ depending on the patient
No comments:
Post a Comment
Note: only a member of this blog may post a comment.